Rodman & Renshaw's Michael King is recommending investors buy the dip in shares of VIVUS (Nasdaq: VVUS) following a negative ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE